Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-06-000025
Filing Date
2006-08-14
Accepted
2006-08-14 10:44:15
Documents
6
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 2ND QUARTER 10Q 2006 biosante10q6-06.htm 10-Q 644494
2 SETTLEMENT AGREEMENT AS AMENDED settlement.htm EX-10.2 121327
3 EXHIBIT 31.1 exhibit31w1.htm EX-31.1 10942
4 EXHIBIT 31.2 exhibit31w2.htm EX-31.2 10927
5 EXHIBIT 32.1 exhibit32w1.htm EX-32.1 4522
6 EXHIBIT 32.2 exhibit32w2.htm EX-32.2 4665
  Complete submission text file 0001023024-06-000025.txt   798407
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 061027509
SIC: 2836 Biological Products, (No Diagnostic Substances)